BNP Paribas Financial Markets’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
BNP Paribas Financial Markets's ATEX Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Anterix (ATEX) stake by 14% in Q2 2026, selling an estimated $20.8K and leaving 2,123 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #4191.
BNP Paribas Financial Markets first reported a position in ATEX in Q2 2015 and has held it in 24 quarters since. The position peaked at $304K in Q3 2022. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- BNP Paribas Financial Markets held 2,123 shares of Anterix worth $219K as of Q2 2026.
- BNP Paribas Financial Markets sold 354 Anterix shares in Q2 2026, an estimated $20.8K.
- Anterix made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4191 holding.
- BNP Paribas Financial Markets first reported a position in Anterix in Q2 2015 and has held it in 24 quarters since.
- BNP Paribas Financial Markets's Anterix position peaked at $304K in Q3 2022.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.